Aspirin DL-lysine Inhibitor

Aspirin DL-lysine is a non-steroidal anti-inflammatory drug. It also may inhibit cancer growth. Aspirin DL-lysine is a water-soluble, injectable aspirin derivative.

Yasu T, Oshima S, Imanishi M, Nonogi H, Haze K, Kuramochi M, Omae T, Hayashi Y, Yamamoto S. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. Am J Cardiol. 1993 May 15;71(13):1164-8. PubMed PMID: 8480641.
Sakakibara H, Tsuda M, Suzuki M, Handa M, Saga T, Umeda H, Suetsugu S, Konishi Y. [A new method of diagnosis of aspirin-induced asthma by inhalation test with water-soluble aspirin (aspirin DL-lysine, Venopirin]. Nihon Kyobu Shikkan Gakkai Zasshi. 1988 Mar;26(3):275-83. Japanese. PubMed PMID: 3148054.
Whittem T, Freeman DA, Parton K, Hanlon DW. The pharmacokinetics of salicylate in dairy cattle are not altered by simultaneous intravenous ceftiofur sodium and DL-lysine-acetyl salicylate (aspirin). J Vet Pharmacol Ther. 1996 Apr;19(2):104-8. PubMed PMID: 8735416.
Nishimura S, Liang RF, Kawabata A, Arai T, Mizuno H, Sakata T, Maruyama S, Tajima M, Sato S. [Effects of aspirin DL-lysine on bone wound healing and bone growth in rats]. Meikai Daigaku Shigaku Zasshi. 1988;17(3):376-84. Japanese. PubMed PMID: 3271922.

Small volumes of Aspirin DL-lysine, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5756432 is an inhibitor targeting Aspirin DL-lysine.